The global intraoperative imaging market size was estimated at USD 3.67 billion in 2024 and is projected to reach USD 5.41 billion by 2030, growing at a CAGR of 6.8% from 2025 to 2030. The growth of this market is primarily driven by the increasing adoption of minimally invasive surgeries and the continuous advancement of imaging technologies that enhance surgical precision and patient outcomes.

In addition, the rising prevalence of chronic disorders and the growth of the geriatric population are significant factors fueling market expansion. The global increase in the elderly population has heightened susceptibility to various medical conditions, necessitating more advanced surgical interventions. According to the World Health Organization (WHO), by 2030, 1 in 6 people worldwide will be aged 60 years or older, underscoring the growing demand for advanced surgical tools, including intraoperative imaging systems.

Intraoperative imaging has emerged as a highly effective tool for performing more accurate and efficient surgeries. By enabling real-time visualization, these technologies not only improve patient outcomes but also optimize workflows and operational efficiency for healthcare professionals both inside and outside the operating room. Technologies such as iUltrasound, C-arm, and iMRI have significantly expanded surgical capabilities, allowing for precise visualization of bones and soft tissues. This precision has transformed surgical care across a wide range of medical disciplines, including neurology, orthopedics, cardiology, and vascular surgery.

Ongoing advancements in intraoperative imaging, such as 3D imaging and real-time imaging, are expected to further accelerate market growth. For example, in March 2021, GE Healthcare received FDA clearance for OEC 3D, a surgical imaging system capable of performing both 2D and 3D imaging. The OEC 3D system aims to set a new benchmark for intraoperative 3D imaging, particularly in spine and orthopedic surgeries, by providing highly accurate volumetric images that improve surgical precision and patient outcomes.

Key Market Trends & Insights:

• In 2024, North America dominated the global intraoperative imaging market, capturing the largest revenue share of 34.6%. The region’s leadership is attributed to the presence of advanced healthcare infrastructure, high adoption of innovative surgical technologies, and increasing demand for minimally invasive procedures. Within North America, the U.S. intraoperative imaging market is expected to continue growing over the forecast period, driven by ongoing technological advancements, favorable government initiatives, and the rising prevalence of chronic and age-related disorders that require precise surgical interventions.

• When analyzed by product, the C-arm segment led the market in 2024, holding the largest revenue share of 31.1%. The C-arm’s widespread adoption is due to its versatility in providing real-time imaging during various surgical procedures, particularly in orthopedics, cardiology, and neurology, enabling surgeons to perform precise interventions with enhanced accuracy.

• By application, the neurosurgery segment accounted for the largest revenue share of approximately 30.8% in 2024. The segment’s dominance is driven by the critical need for high-precision imaging to guide complex neurosurgical procedures, ensuring better patient outcomes and reduced procedural risks.

• In terms of end use, the ambulatory surgical centers (ASCs) segment is projected to register the fastest CAGR during the forecast period. The rapid growth of ASCs is fueled by their increasing popularity as cost-effective, efficient, and convenient alternatives to traditional hospital-based surgeries, coupled with rising adoption of advanced intraoperative imaging technologies to enhance surgical precision and workflow efficiency.

Order a free sample PDF of the Intraoperative Imaging Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 3.67 Billion

• 2030 Projected Market Size: USD 5.41 Billion

• CAGR (2025–2030): 6.8%

• North America: Largest market in 2024

• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights:

Key players in the intraoperative imaging industry are actively working to enhance their product portfolios and strengthen their market positions. Companies are achieving this through product upgrades, strategic partnerships, mergers and acquisitions, as well as securing government approvals to expand their customer base and capture a larger share of the global market. These initiatives enable companies to stay competitive, improve technological capabilities, and offer more comprehensive solutions to healthcare providers.

For example, in January 2023, GE Healthcare announced its plan to acquire IMACTIS, a move aimed at enhancing its capabilities in interventional guidance. This strategic acquisition is designed to broaden GE Healthcare’s portfolio in the interventional imaging space, enabling the company to provide more advanced and integrated solutions for minimally invasive procedures. The acquisition also reflects GE Healthcare’s ongoing commitment to precision care, innovation, and driving growth in the intraoperative imaging market.

Key Players

• GE HealthCare

• Siemens Healthcare GmbH

• Medtronic plc

• Koninklijke Philips N.V.

• Canon Medical Systems Corporation

• Shimadzu Corporation (Medical Systems)

• Brainlab AG

• Ziehm Imaging GmbH

• IMRIS

• NeuroLogica Corp.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The global intraoperative imaging market is experiencing significant growth, driven by the increasing adoption of minimally invasive surgeries and advancements in imaging technologies. North America holds a dominant position in the market, with the United States leading in both market share and growth rate. The C-arm segment remains the largest revenue contributor, while the service segment is witnessing the fastest growth. Looking ahead, the market is expected to continue its expansion, with on-premise deployment models anticipated to experience significant growth over the forecast period.